Simhadri Prathap Kumar, Koller Felicitas, Matemavi Praise, Earl Mark Truman, Chandramohan Deepak, Vaitla Pradeep K
Division of Nephrology, Advent Health/FSU College of Medicine, Daytona Beach, FL.
Division of Transplant and Hepatobiliary Surgery, University of Mississippi Medical Center, Jackson, MS.
Kidney Med. 2024 Jul 20;6(9):100875. doi: 10.1016/j.xkme.2024.100875. eCollection 2024 Sep.
People with sickle cell disease experience a high incidence of chronic kidney disease and end-stage kidney disease, secondary to tubular and glomerular effects of vaso-occlusion-induced hypoxia. Because of concerns of suboptimal kidney function, sickle cell donors are usually not considered for kidney donation, even if the rest of the parameters are acceptable for organ donation. A significant gap exists between the number of organ donors and the number of candidates waiting for a kidney transplant in the United States. To bridge the gap, we need to consider using nontraditional donors. We report kidney transplant outcomes in 6 recipients from 4 sickle cell kidney donors. Intracranial hemorrhage and sepsis were the causes of the death in donors, and no donor was in sickle cell crisis at the time of donation. None of the recipients experienced delayed graft function, and all recipients achieved excellent allograft function. The earliest allograft failure was at 27 months in a recipient who developed early acute rejection, while the longest follow-up was 10 years with adequate kidney function. In conclusion, given the shortage of kidneys for transplantation and demonstrated good outcomes, we propose that kidneys from sickle cell donors can be safely used.
镰状细胞病患者慢性肾脏病和终末期肾病的发病率很高,这是血管阻塞性缺氧对肾小管和肾小球产生影响的继发结果。由于担心肾功能欠佳,镰状细胞病患者通常不被考虑作为肾脏供体,即便其他参数符合器官捐献的条件。在美国,器官捐献者的数量与等待肾移植的候选者数量之间存在显著差距。为了缩小这一差距,我们需要考虑使用非传统供体。我们报告了4名镰状细胞病肾脏供体为6名受者进行肾脏移植的结果。供体的死因是颅内出血和败血症,且捐献时没有供体处于镰状细胞危象状态。所有受者均未出现移植肾功能延迟,且所有受者的移植肾功能均良好。最早出现移植肾失功的是一名发生早期急性排斥反应的受者,时间为27个月,而最长随访时间为10年,肾功能良好。总之,鉴于肾脏移植供体短缺且已证明有良好的结果,我们建议可以安全地使用镰状细胞病供体的肾脏。